<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,109.065,112.801,116.926,118.431,122.943,124.96,126.481,130.217,134.341,138.466,140.029,147.501,149.518,151.027,155.54,157.557,161.682,163.215,168.969,171.846,173.863,175.404,178.669,181.07500000000002,182.66,186.396,188.414,190.43099999999998,191.958,196.47,200.595,204.719,208.45499999999998,209.985,214.109,218.234,222.358,225.623,229.748,233.872,235.889,240.014,243.75,245.302,250.666,256.808,262.173,263.726,267.85,273.215,278.116,282.241,283.793,287.918,290.794,294.919,301.061,305.185,307.591,310.856,313.733,315.312,319.436,323.56,327.685" y="37.76400000000001" svg_rhmargin="330.091" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[32] Wan L, Sun M, Liu GJ, et al. Long noncoding RNA PVT1 promotes non-</text>
  <text x="101.594,104.47,110.612,114.348,116.365,118.38199999999999,120.301,123.566,126.831,128.848,130.865,132.773,134.79,138.914,143.039,146.77499999999998,148.646,151.911,155.647,159.771,163.036,166.302,169.179,171.094,174.359,177.624,179.642,181.659,183.566,187.69,190.567,194.691,196.709,198.726,201.132,204.397,207.274,211.01,213.416,215.433,219.558,223.683,225.628,228.034,232.159,235.035,239.16,243.284,247.02,251.145,253.066,256.331,260.455,262.473,266.209,269.474,273.598,276.863,279.269,281.287,284.552,288.288,290.305,292.322,296.058,298.019,300.896,304.161,307.897,312.021,314.039,317.774,320.18,322.198,326.322" y="46.721000000000004" svg_rhmargin="330.058" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">small cell lung cancer cell proliferation through epigenetically regulating</text>
  <text x="101.594,106.107,111.471,116.373,120.109,124.234,126.763,131.277,135.401,139.526,142.402,145.667,148.544,151.421,153.438,157.563,161.687,163.704,166.219,173.69,177.815,179.832,182.375,187.74,191.476,195.6,198.865,202.13,205.007,207.544,212.446,216.57,219.836,222.71300000000002,225.175,229.3,233.425,237.549,241.673,243.691,247.815,251.94,254.03,258.154,262.278,266.403" y="55.678" svg_rhmargin="270.527" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">LATS2 Expression. Mol Cancer Ther 2016;15:1082</text>
  <text x="270.538" y="55.678" svg_rhmargin="274.274" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="274.28,278.405,282.53" y="55.678" svg_rhmargin="284.547" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">94.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,109.065,112.801,116.926,120.662,122.115,126.239,128.256,129.655,135.019,139.144,142.88,147.005,148.475,151.352,157.576,159.593,161.003,168.475,172.211,176.335,180.071,181.525,185.261,189.774,191.791,193.259,196.524,198.93,200.345,204.081,206.099,208.11599999999999,209.586,215.728,219.852,223.117,227.242,229.648,232.913,235.319,239.055,241.072,242.578,244.596,248.72,252.844,256.58,257.998,262.122,266.247,270.371,273.636,277.761,281.885,283.902,288.027,291.763,293.258,298.623,304.764,310.129,311.568,315.693,321.057,325.959" y="64.63599999999997" svg_rhmargin="330.083" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[33] Wang F, Yuan JH, Wang SB, et al. Oncofetal long noncoding RNA PVT1</text>
  <text x="101.594,105.718,108.595,112.719,118.861,122.985,125.391,128.656,131.53300000000002,135.55,139.674,142.551,146.675,148.693,150.71,153.116,156.381,159.258,162.994,165.4,167.417,171.542,175.667,179.71,183.446,187.57,191.695,195.696,198.573,200.979,204.244,210.386,214.404,217.67,220.935,222.952,224.969,227.375,229.393,231.41,235.535,238.79999999999998,242.862,246.987,249.863,253.988,258.112,261.377,264.254,266.66,270.396,274.381,278.506,280.912,284.925,289.05,292.315,296.439,300.175,302.581,306.706,309.971,313.236,315.253,317.271,321.395,323.413,327.148" y="73.59299999999996" svg_rhmargin="330.025" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">promotes proliferation and stem cell-like property of hepatocellular</text>
  <text x="101.594,104.859,108.595,111.471,114.736,116.754,120.878,125.003,131.145,134.881,137.421,140.686,143.951,145.969,147.986,150.863,153.351,157.475,161.21099999999998,163.725,166.602,169.008,172.744,176.868,178.886,180.903,182.92,186.186,188.203,192.327,196.063,198.646,204.787,210.929,215.054,219.178,221.195,223.701,229.925,233.191,237.315,241.051,243.457,247.581,249.599,253.803,257.539,261.275,263.781,267.905,272.03,276.154,280.279,282.296,286.42,290.545,292.562,296.687,300.811,304.936" y="82.54999999999995" svg_rhmargin="309.06" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoma cells by stabilizing NOP2. Hepatology 2014;60:1278</text>
  <text x="309.088" y="82.54999999999995" svg_rhmargin="312.824" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="312.83,316.956,321.081" y="82.54999999999995" svg_rhmargin="323.098" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">90.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,107.347,111.472,113.555,121.027,126.78,128.797,130.902,138.374,142.109,146.234,149.97,152.103,157.468,159.48499999999999,161.627,169.098,172.363,176.488,180.224,182.318,189.79,191.807,193.94,197.205,199.61100000000002,201.707,205.443,207.46,209.477,211.571,216.936,219.055,223.179,227.304,230.18,232.198,234.604,236.621,240.357,243.62199999999999,245.755,248.161,251.426,254.691,258.816,262.94,266.676,270.018,274.143,276.197,278.214,282.339,286.463,290.588,292.75,296.874,299.28000000000003,301.367,303.384,307.509,310.774,316.139,322.281,327.645" y="91.56399999999996" svg_rhmargin="330.051" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[34] Xu MD, Wang Y, Weng W, et al. A positive feedback loop of lncRNA-</text>
  <text x="101.594,105.718,111.083,115.984,120.109,122.455,126.191,130.315,134.44,136.797,140.921,147.063,152.816,160.288,164.413,166.842,169.248,172.984,176.249,178.266,180.284,182.301,184.707,188.443,190.849,194.114,196.991,199.381,203.117,206.853,209.729,212.135,215.012,217.029,220.29399999999998,222.68,225.945,229.681,233.806,237.136,240.401,243.27800000000002,245.639,249.375,252.252,256.376,262.13,264.536,268.661,271.036,274.772,278.896,283.021,285.379,287.396,291.521,295.257,298.993,301.869,303.887,308.011,312.135,314.152,316.557,321.922,323.939,325.957" y="100.52099999999996" svg_rhmargin="330.081" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 and FOXM1 facilitates gastric cancer growth and invasion. Clin</text>
  <text x="101.594,106.958,110.694,114.819,118.084,121.349,124.226,126.763,132.128,135.393,138.27,140.765,144.89,149.014,153.139,157.263,159.28,163.405,167.529,169.547,173.671,177.795,181.92" y="109.47799999999995" svg_rhmargin="186.044" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cancer Res 2017;23:2071</text>
  <text x="186.122" y="109.47799999999995" svg_rhmargin="189.858" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="189.864,193.989,198.114" y="109.47799999999995" svg_rhmargin="200.131" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">80.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,106.958,110.694,114.819,118.555,120.018,125.382,130.747,132.764,134.246,139.611,143.347,147.471,151.207,152.67,156.406,161.771,163.78799999999998,165.255,170.62,174.745,178.869,182.994,186.73,188.157,193.522,198.035,200.052,201.536,204.801,207.207,208.679,212.415,214.432,216.44899999999998,217.919,220.325,224.449,227.715,230.591,233.856,237.592,240.469,243.734,247.859,249.325,252.59,256.714,260.839,263.78,267.045,269.922,272.799,274.816,278.94,283.065,284.529,288.653,291.059,292.522,294.928,299.052,302.317,303.746,305.763,309.888,313.153,318.598,324.74" y="118.43600000000004" svg_rhmargin="330.105" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[35] Yang YR, Zang SZ, Zhong CL, et al. Increased expression of the lncRNA</text>
  <text x="101.594,105.718,111.083,115.984,120.109,122.682,126.806,129.683,133.807,139.949,144.074,146.48,149.745,152.622,155.221,157.627,161.751,167.893,172.018,174.894,176.912,180.73,183.996,188.12,191.385,194.262,196.279,199.156,201.762,203.779,207.904,210.493,214.617,218.742,222.866,225.272,228.149,234.291,238.026,240.044,242.061,244.676,247.941,251.206,253.223,255.24,257.827,259.845,263.969,268.094,271.83,274.437,277.702,281.438,285.563,288.828,292.093,294.97,296.987,299.55,301.956,306.08,308.486,311.115,313.992,316.557,321.922,323.939,325.957" y="127.39300000000003" svg_rhmargin="330.081" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin</text>
  <text x="101.594,106.107,110.231,114.356,116.843,120.967,124.703,127.109,131.233,135.358,137.375,139.915,144.039,148.164,152.288,156.413,158.43,162.554,164.572,168.696,172.821,176.945" y="136.35000000000002" svg_rhmargin="181.069" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Exp Pathol 2014;7:6929</text>
  <text x="181.133" y="136.35000000000002" svg_rhmargin="184.869" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="184.875,189.0,193.125" y="136.35000000000002" svg_rhmargin="195.142" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">35.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,106.958,111.082,114.818,118.943,121.774,127.139,131.652,133.66899999999998,136.513,141.026,143.043,145.867,152.091,154.108,156.978,162.343,166.467,170.592,173.418,177.932,179.94899999999998,182.773,186.038,188.44400000000002,191.277,195.013,197.03,199.047,201.878,207.243,211.367,214.632,217.509,220.385,224.121,228.246,230.65200000000002,233.51,236.775,240.899,245.024,247.965,251.231,254.107,256.984,259.001,263.126,267.251,270.074,274.199,276.605,279.428,281.446,285.57,289.695,293.431,296.322,300.447,304.571,308.695,311.961,316.085,320.209,322.227,326.351" y="145.36400000000003" svg_rhmargin="330.087" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[36] Yuan CL, Li H, Zhu L, et al. Aberrant expression of long noncoding</text>
  <text x="101.594,106.958,113.1,118.46499999999999,121.549,125.673,131.038,136.004,140.129,143.204,146.94,151.064,155.189,158.284,160.301,162.707,165.584,168.658,172.783,174.8,178.536,182.272,186.396,190.597,193.474,195.879,197.897,201.16199999999998,204.259,207.995,212.119,216.244,219.339,223.463,226.34,230.464,234.2,238.325,242.449,245.326,247.732,249.749,253.01399999999998,256.129,259.006,261.023,264.759,268.883" y="154.32100000000003" svg_rhmargin="270.9" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">RNA PVT1 and its diagnostic and prognostic signi</text>
  <text x="270.991" y="154.32100000000003" svg_rhmargin="275.115" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="275.073,278.338,282.074,286.199,289.529,292.794,295.878,297.896,302.021,305.119,309.243,312.979,315.385,317.402,320.667,324.792,327.198" y="154.32100000000003" svg_rhmargin="330.075" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance in patients</text>
  <text x="101.594,107.347,109.364,111.77,115.895,118.374,122.11,125.846,128.722,131.128,134.077,136.094,139.35899999999998,141.843,145.109,148.845,152.969,156.234,159.499,162.376,164.393,166.956,173.098,176.363,180.488,184.612,186.629,190.365,193.242,199.384,203.11999999999998,205.674,209.799,213.923,218.048,222.172,224.189,228.314,232.438,234.456,238.58,242.705" y="163.27800000000002" svg_rhmargin="246.829" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">with gastric cancer. Neoplasma 2016;63:442</text>
  <text x="246.84" y="163.27800000000002" svg_rhmargin="250.576" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="250.582,254.707" y="163.27800000000002" svg_rhmargin="256.724" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,106.958,111.082,114.818,118.942,122.678,124.212,129.965,131.982,133.565,137.301,141.426,145.551,147.114,152.868,154.885,156.469,161.833,165.958,169.694,173.818,177.554,179.144,185.368,187.385,188.952,192.217,194.62300000000002,196.151,199.887,201.905,203.922,205.505,210.018,214.143,218.267,222.003,223.589,227.714,231.838,235.963,238.369,241.634,245.758,249.883,251.9,256.024,259.76,261.344,266.708,272.85,278.21500000000003,279.768,283.892,289.257,294.223,298.348,299.893,302.299,306.035,309.3,311.317,313.335,315.352,317.758,321.494,323.9,327.165" y="172.236" svg_rhmargin="330.042" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[37] Zhang D, Sun G, Zhang H, et al. Long non-coding RNA PVT1 facilitates</text>
  <text x="101.594,104.859,108.124,111.001,114.736,116.754,120.019,123.755,125.77199999999999,127.273,130.539,134.275,138.399,141.664,144.929,147.806,149.268,153.393,156.269,160.394,164.13,167.006,170.271,173.148,176.025,178.122,182.246,186.371,187.816,190.222,194.346,197.223,201.347,205.472,209.208,213.333,214.8,218.924,222.189,225.925,229.661,232.067,234.084,237.82,241.08499999999998,242.577,248.719,252.843,257.033,261.158,263.175,266.911,269.317,271.334,275.459,279.584,281.069,285.194,287.6,289.063,295.204,297.222,302.587,304.992,309.117,313.241,317.366,319.772,323.896,328.02" y="181.19299999999998" svg_rhmargin="330.037" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cervical cancer progression through negative modulation of miR-128-3p.</text>
  <text x="101.594,104.0,108.125,110.531,113.046,115.923,118.375,123.741,125.759,127.777,131.902,134.421,138.935,143.06,147.185,149.728,153.854,157.59,159.997,164.122,168.247,170.264,172.804,176.93,181.055,185.18,189.305,191.323,195.448,199.574,201.592,205.717,209.842,213.967" y="190.14999999999998" svg_rhmargin="218.091" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Int J Clin Exp Pathol 2017;10:4522</text>
  <text x="218.097" y="190.14999999999998" svg_rhmargin="221.833" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="221.839,225.963" y="190.14999999999998" svg_rhmargin="227.98" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,106.958,111.082,114.818,118.943,122.228,126.741,128.758,132.036,137.401,141.526,145.65,149.386,152.672,158.896,160.91299999999998,164.18,167.916,172.041,176.166,179.43,185.654,187.671,190.938,194.204,196.61,199.896,203.632,205.649,207.666,210.95,215.463,219.588,222.853,228.217,234.359,239.724,242.13,246.254,251.619,256.521,260.646,263.954,268.078,270.955,275.079,281.221,285.345,287.751,291.107,293.98400000000004,297.23,301.355,305.091,309.215,312.481,315.357,318.622,322.358,324.764,326.782" y="199.10699999999997" svg_rhmargin="330.047" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[38] Zhao L, Kong H, Sun H, et al. LncRNA-PVT1 promotes pancreatic</text>
  <text x="101.594,104.859,108.595,112.719,115.984,119.249,122.12599999999999,124.836,128.101,131.366,133.384,135.401,138.27800000000002,140.992,145.117,147.993,152.118,154.135,156.153,158.559,161.824,164.7,168.436,170.842,172.964,177.089,181.214,183.905,187.641,191.766,195.891,198.588,204.73,206.747,210.483,213.36,217.096,219.502,221.519,225.643,229.768,232.488,234.893,239.018,241.895,246.019,250.143,253.879,258.004,260.718,264.454,267.719,270.125,272.143,276.267,280.003,282.714,286.45,289.327,292.068,295.804,298.474,304.617,308.741,310.758,314.024,317.289,321.413,323.431,327.166" y="208.12099999999998" svg_rhmargin="330.043" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer cells proliferation and migration through acting as a molecular</text>
  <text x="101.594,104.47,108.595,112.719,116.844,120.579,123.844,126.366,128.772,132.897,135.38,138.257,141.522,145.258,149.383,151.4,155.136,157.542,160.807,163.328,169.47,171.487,176.852,179.258,183.382,187.59,191.715,193.732,196.207,199.084,201.593,206.959,210.224,212.241,214.258,216.786,220.911,225.035,228.771,231.648,233.665,237.79,239.807,242.353,246.478,250.602,254.727,258.851,260.868,264.993,269.117,273.242,275.259,279.384,283.508,287.632" y="217.07799999999997" svg_rhmargin="291.756" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">sponge to regulate miR-448. J Cell Physiol 2018;233:4044</text>
  <text x="291.797" y="217.07799999999997" svg_rhmargin="295.533" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="295.539,299.664,303.789" y="217.07799999999997" svg_rhmargin="305.806" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">55.</text>
  <text x="85.209,87.615,91.74,95.864,98.27000000000001,101.593,106.958,111.082,114.347,118.472,122.208,125.686,131.439,133.456,136.911,143.135,147.26,150.686,156.91,158.927,162.421,166.934,168.951,172.398,176.134,178.15099999999998,181.581,187.805,189.823,193.559,197.684,201.196,204.461,208.585,212.71,215.586,218.852,221.728,224.605,226.622,230.747,234.872,238.384,242.508,244.91400000000002,248.361,250.379,254.503,257.768,263.133,269.275,274.64,278.123,282.248,287.612,292.514,296.639,300.119,304.243,307.12,311.244,317.386,321.51,323.916,327.181" y="226.03599999999994" svg_rhmargin="330.058" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[39] Zheng X, Hu H, Li S. High expression of lncRNA PVT1 promotes</text>
  <text x="101.594,103.611,107.735,111.471,115.207,118.084,120.101,124.226,128.351,130.221,134.346,138.082,139.915,141.932,146.057,150.181,154.371,157.636,159.653,163.778,167.51399999999998,169.393,172.659,176.783,178.8,181.206,185.331,188.596,190.613,192.631,196.367,198.384,200.79,203.196,207.32,209.726,215.868,219.133,222.01,225.275,229.539,232.804,236.929,240.665,246.807,250.542,252.559,254.426,256.831,259.708,263.444,267.568,270.445,272.462,274.868,276.886,281.01,285.135,287.021,289.039,293.164,295.071,298.337,301.213,305.338,309.462,313.586,317.322,321.058,324.323,328.059" y="234.99300000000005" svg_rhmargin="330.076" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">invasion by inducing epithelial-to-mesenchymal transition in esophageal</text>
  <text x="101.594,104.859,108.595,112.719,115.984,119.249,122.126,124.143,126.65,132.791,136.916,140.181,144.305,146.322,148.871,153.385,156.65,159.056,161.46200000000002,163.952,168.076,172.201,176.325,180.45,182.467,186.591,190.716,192.806,196.93,201.054,205.179" y="243.95000000000005" svg_rhmargin="209.303" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer. Oncol Lett 2016;12:2357</text>
  <text x="209.309" y="243.95000000000005" svg_rhmargin="213.045" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="223.319" x="213.051,217.176,221.302,223.319" y="37.759000000000015" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">62. </text>
  <text x="345.202,347.608,351.732,355.857,358.26300000000003,361.585,366.95,371.074,375.199,378.935,383.127,386.863,388.286,393.652,395.669,397.188,401.701,403.718,405.182,408.058,410.075,411.531,416.045,418.062,422.187,423.664,429.029,431.046,432.564,435.83,438.236,439.707,443.443,445.461,447.478,448.948,453.849,457.114,459.52,462.397,466.133,469.398,473.134,476.399,478.417,480.434,484.558,487.824,490.33,492.347,496.471,500.596,504.72,507.985,510.003,514.127,516.145,519.41,520.885,523.761,527.886,533.251,539.479,544.844,546.282,548.688,552.424,555.301,559.037,562.302,564.708,566.725,570.85,574.586,576.1,578.117,582.242,586.366" y="37.759000000000015" svg_rhmargin="590.102" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[40] Zhuang C, Li J, Liu Y, et al. Tetracycline-inducible shRNA targeting long</text>
  <text x="361.586,365.711,369.835,373.959,376.365,379.63,383.755,387.879,389.897,394.021,397.757,400.814,406.179,412.321,417.68600000000004,420.713,424.837,430.202,435.168,439.293,442.254,444.272,448.396,452.521,454.538,458.663,460.68,463.173,466.05,469.012,472.277,475.542,477.559,479.576,482.617,486.353,489.23,493.354,499.107,501.513,505.638,508.694,512.43,516.554,520.679,523.66,525.677,529.802,533.926,538.05,541.316,544.581,547.458,550.53,554.266,558.39,562.515,566.639,569.045,573.17,576.046,578.064,580.9409999999999,583.976,585.993" y="46.71600000000001" svg_rhmargin="590.117" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">non-coding RNA PVT1 inhibits cell growth and induces apoptosis in</text>
  <text x="361.586,365.711,367.728,371.464,375.588,379.713,382.978,385.855,388.399,391.665,395.4,399.525,402.79,406.055,408.932,411.471,414.737,418.002,420.019,422.037,424.913,426.93,429.442,435.584,439.708,442.973,447.098,449.504,453.24,456.116,459.852,463.117,465.523,468.103,472.228,476.352,480.476,484.601,486.618,490.743,492.76,496.885,501.009,505.133,509.258" y="55.67399999999998" svg_rhmargin="513.382" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">bladder cancer cells. Oncotarget 2015;6:41194</text>
  <text x="513.409" y="55.67399999999998" svg_rhmargin="517.145" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="517.15,521.276,525.401,529.526" y="55.67399999999998" svg_rhmargin="531.543" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">203.</text>
  <text x="345.202,347.608,351.732,355.857,358.26300000000003,361.585,366.098,368.116,372.241,375.701,381.066,383.08299999999997,386.53,391.895,396.019,399.284,403.409,406.882,414.354,416.371,419.808,425.172,429.297,432.562,436.687,440.159,445.525,447.542,450.988,454.253,456.659,460.116,463.852,465.869,467.886,471.341,476.706,480.185,484.31,487.575,493.328,496.796,500.061,502.079,505.815,508.691,511.568" y="64.63099999999997" svg_rhmargin="513.585" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[41] Lin Z, Chen W, Chen Y, et al. A new classi</text>
  <text x="513.579" y="64.63099999999997" svg_rhmargin="517.703" style="fill:#171615;font-family:NCNEBP+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="517.718,520.983,524.72,527.127,529.145,533.27,537.395,540.907,545.032,547.438,550.886,552.904,556.64,562.783,566.908,571.033,574.471,578.596,582.721,586.847" y="64.63099999999997" svg_rhmargin="590.112" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cation of lymph node</text>
  <text x="361.586,367.728,370.993,373.399,377.135,380.012,382.504,386.24,389.117,392.382,395.259,396.846,400.582,403.847,407.112,411.237,414.114,418.238,420.255,424.453,428.18899999999996,429.782,432.188,436.313,437.889,440.295,444.419,447.68399999999997,449.34,451.357,455.093,461.235,465.36,469.485,471.108,475.233,479.357,483.482,486.747,488.342,491.219,493.625,497.36,499.766,501.784,505.908,510.033,512.91,514.589,516.995,521.119,523.996,525.587,529.711,532.588,535.853,539.977,541.995,545.26,547.666,549.683,553.808,557.544,559.203,563.328,566.204,570.329,574.065,578.189,582.314,585.19,587.208" y="73.58799999999997" svg_rhmargin="590.085" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">metastases according to the lymph node stations for predicting prognosis</text>
  <text x="361.586,363.603,367.728,374.228,377.105,381.229,384.106,387.842,389.859,393.125,396.86,398.877,405.351,409.475,413.211,415.617,417.634,420.899,425.024,427.43,430.307,436.813,442.566,444.584,446.989,451.114,457.561,460.826,463.703,467.828,472.017,476.141,479.877,483.613,486.878,490.614,492.631,499.114,501.991,506.115,510.24,513.976,520.117,524.242,528.366,531.2429999999999,537.719,540.985,544.25,546.267,548.2840000000001,554.727,557.992,561.728,564.605,567.87,569.887,574.012,578.136,584.375,588.111" y="82.54499999999996" svg_rhmargin="590.128" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in surgical patients with esophageal squamous cell carcinoma.</text>
  <text x="361.586,367.728,371.852,375.117,379.242,381.648,385.384,388.343,392.078,395.344,397.75,400.247,404.372,408.496,412.621,416.745,418.762,422.887,424.904,429.029,433.153,437.277,441.402" y="91.55899999999997" svg_rhmargin="445.526" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Oncotarget 2016;7:76261</text>
  <text x="445.604" y="91.55899999999997" svg_rhmargin="449.34" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="449.346,453.471,457.596" y="91.55899999999997" svg_rhmargin="459.613" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="345.202,347.608,351.732,355.857,358.26300000000003,361.585,367.339,371.463,375.199,379.324,383.241,389.465,391.48199999999997,395.429,402.901,406.166,408.183,412.095,417.461,419.478,423.434,430.906,432.923,436.814,442.179,444.19599999999997,448.152,451.417,453.823,457.733,461.469,463.486,465.503,469.412,475.165,479.289,485.043,489.167,492.044,495.309,499.045,503.254,505.272,509.008,511.413,513.431,517.555,521.68,525.59,529.714,532.12,536.078,538.095,542.22,545.485,550.85,556.992,562.357,566.293,571.658,577.8,583.165,585.57" y="100.51599999999996" svg_rhmargin="590.083" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[42] Guan H, Mei Y, Mi Y, et al. Downregulation of lncRNA ANRIL</text>
  <text x="361.586,364.463,368.587,372.712,376.836,379.713,382.978,385.854,388.731,392.084,394.961,397.754,401.49,404.367,408.491,414.244,416.65,420.775,423.604,427.34,431.465,435.59,438.4,444.542,447.808,450.213,453.949,456.826,459.319,463.054,465.931,467.949,470.826,473.661,475.678,479.803,482.618,486.742,490.867,497.009,500.744,504.869,507.675,511.799,514.676,517.082,520.347,524.471,527.348,531.084,533.96,537.323,541.447,547.589,551.325,554.103,557.368,560.633,562.651,564.668,567.545,569.562,572.47,578.612,582.736,586.002" y="109.47400000000005" svg_rhmargin="590.126" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">suppresses growth and metastasis in human osteosarcoma cells. Onco</text>
  <text x="361.586,366.488,370.223,373.1,376.836,380.101,382.507,385.384,387.946,392.847,396.972,400.237,403.11400000000003,405.633,409.757,413.882,418.006,422.131,424.148,428.273,432.397,434.414,438.539,442.663,446.788" y="118.43100000000004" svg_rhmargin="450.912" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Targets Ther 2018;11:4893</text>
  <text x="450.934" y="118.43100000000004" svg_rhmargin="454.67" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="454.676,458.801" y="118.43100000000004" svg_rhmargin="460.818" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="345.203,347.609,351.733,355.857,358.26300000000003,361.586,369.058,371.075,373.952,377.217,380.953,384.218,386.235,389.023,395.247,397.264,400.021,405.774,409.899,414.023,416.04,419.776,425.918,427.936,432.061,434.828,438.563,440.58,443.331,447.067,451.192,454.927,459.052,461.069,465.194,468.07,471.806,473.824,477.089,479.966,482.729,486.465,488.48199999999997,491.233,494.498,496.904,499.68,503.416,505.433,507.45,510.167,517.639,519.656,522.922,525.87,529.994,535.359,541.501,546.866,549.7429999999999,552.514,556.25,559.127,561.868,565.992,570.117,572.523,575.788,579.912,582.318,584.336,588.071" y="127.38800000000003" svg_rhmargin="590.088" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[43] Mirzaei H, Gholamin S, Shahidsales S, et al. MicroRNAs as potential</text>
  <text x="361.587,365.711,367.729,371.465,375.2,379.325,383.449,386.326,388.732,390.837,394.102,398.548,402.283,406.408,410.533,414.931,419.055,421.932,426.056,429.792,433.978,438.102,440.979,443.385,445.402,448.667,453.139,457.263,459.28,463.405,469.547,473.283,476.159,480.284,483.549,486.426,489.303,493.784,495.801,499.926,504.385,510.527,513.792,515.809,519.545,523.669,527.794,533.936,537.672,539.6890000000001,544.18,548.693,552.818,555.6949999999999,560.11,562.987,567.48,572.845,576.581,580.706,583.971,587.236" y="136.34500000000003" svg_rhmargin="590.113" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">diagnostic and prognostic biomarkers in melanoma. Eur J Cancer</text>
  <text x="361.587,365.711,369.836,373.96,378.084,380.102,384.226,388.351,390.441,394.565" y="145.35900000000004" svg_rhmargin="398.689" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2016;53:25</text>
  <text x="398.663" y="145.35900000000004" svg_rhmargin="402.399" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="402.405,406.53,410.656" y="145.35900000000004" svg_rhmargin="412.673" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="345.203,347.609,351.733,355.857,358.26300000000003,361.586,365.71,369.446,373.571,376.269,381.634,387.858,389.875,392.539,397.903,401.168,403.876,411.348,417.572,419.589,422.3,429.772,433.897,436.53,441.043,443.06,445.77,449.035,451.44100000000003,454.103,457.839,459.857,461.874,464.534,470.676,474.412,477.677,480.633,483.899,488.023,492.147,495.024,498.289,501.166,504.043,506.06,510.184,514.309,517.027,521.151,523.5569999999999,526.211,532.353,534.371,539.735,542.141,546.266,550.391,553.082,555.099,559.223,563.348,565.44,569.564,571.582,573.988,576.865,579.556,582.821,586.086,588.104" y="154.31600000000003" svg_rhmargin="590.121" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[44] Fan YH, Ye MH, Wu L, et al. Overexpression of miR-98 inhibits cell</text>
  <text x="361.587,363.604,367.729,371.465,375.2,378.077,380.094,384.219,388.344,390.441,392.459,396.584,398.662,402.398,404.415,406.433,410.557,416.699,420.435,422.528,425.793,429.058,431.075,433.092,435.112,437.13,439.147,443.271,446.62,449.497,451.496,455.232,457.249,460.985,463.061,467.185,471.309,477.063,481.187,484.064,487.329,491.065,495.259,497.277,501.013,503.419,505.436,509.56,513.685,515.724,519.848,522.2539999999999,524.341,526.747,532.112,537.477,540.742,544.866,547.743,549.76,551.778,555.902,560.027,562.0440000000001,564.193,568.706,572.83,575.707,577.742,583.107,586.372" y="163.274" svg_rhmargin="590.108" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">invasion in glioma cell lines via downregulation of IKKepsilon. Eur Rev</text>
  <text x="361.587,369.059,372.324,376.449,378.99,383.115,387.239,390.975,393.851,399.993,403.729,406.994,411.119,413.136,415.667,419.403,422.668,424.685,427.175,431.299,435.424,439.548,443.673,445.69,449.814,453.939,456.029,460.153,464.278,468.402" y="172.231" svg_rhmargin="472.526" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Med Pharmacol Sci 2015;19:3593</text>
  <text x="472.534" y="172.231" svg_rhmargin="476.27" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="476.276,480.401,484.526,488.651" y="172.231" svg_rhmargin="490.668" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">604.</text>
  <text x="345.203,347.609,351.733,355.857,358.26300000000003,361.586,367.728,369.745,372.301,376.425,378.442,380.974,386.727,390.852,393.389,399.142,401.159,403.707,408.608,412.733,415.998,418.502,420.52,424.644,428.769,432.505,435.055,439.181,443.305,447.429,449.835,453.101,457.225,461.349,463.367,467.491,471.227,473.774,479.139,485.281,490.646,493.522,495.539,498.093,501.829,504.386,508.511,511.776,517.529,520.033,523.298,527.034,531.158,534.424,537.689,540.5659999999999,543.105,547.23,549.247,552.983,556.719,560.843,565.043,567.92,570.326,572.343,575.608,578.138,581.874,585.999" y="181.188" svg_rhmargin="590.123" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[45] Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and</text>
  <text x="361.587,363.993,368.117,371.382,374.259,377.995,382.119,385.384,389.591,391.997,394.014,397.279,399.795,403.531,407.656,409.673,413.798,416.292,422.434,424.451,428.576,431.841,433.858,436.36,443.832,447.956,452.081,454.614,458.738,462.474,464.88,469.004,473.129,475.146,477.686,481.81,485.935,490.059,494.183,496.201,500.325,504.45,506.467,510.591,514.716" y="190.14499999999998" svg_rhmargin="518.84" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">therapeutic gold mine. Mod Pathol 2013;26:155</text>
  <text x="518.909" y="190.14499999999998" svg_rhmargin="522.645" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="522.65,526.775,530.899" y="190.14499999999998" svg_rhmargin="532.916" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">65.</text>
  <text x="345.203,347.609,351.733,355.857,358.26300000000003,361.586,366.951,371.075,374.34,378.465,381.314,387.068,389.085,391.859,397.613,401.349,405.474,408.3,414.053,416.07,418.901,423.414,425.431,429.556,432.336,436.072,438.089,440.897,444.162,446.568,449.401,453.136,455.154,457.171,459.945,464.458,468.582,472.707,476.443,479.276,483.4,487.525,491.649,494.914,499.039,503.163,505.18,509.305,513.041,515.84,521.204,527.346,532.711,535.568,539.692,545.057,549.958,554.083,556.882,560.618,563.495,566.293,570.029,572.813,576.937,581.062,584.798,588.063" y="199.10199999999998" svg_rhmargin="590.08" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[46] Chen X, Gao G, Liu S, et al. Long noncoding RNA PVT1 as a novel</text>
  <text x="361.587,365.711,367.729,371.465,375.2,379.325,383.449,386.326,388.732,390.837,394.102,396.109,400.234,402.251,406.376,412.518,416.253,419.13,423.255,426.52,429.397,431.426,435.162,439.287,443.412,445.429,447.834,451.959,455.224,458.101,461.837,465.961,469.226,473.351,475.757,477.774,481.039,483.126,485.532,489.268,492.144,495.88,499.146,501.552,503.59,505.996,510.121,512.9979999999999,514.985,521.127,524.392,526.409,530.145,534.27,538.394,544.536,548.272,550.2890000000001,552.343,556.856,558.874,562.998,569.14,572.405,576.53,578.59,583.956,587.221" y="208.11599999999999" svg_rhmargin="590.098" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">diagnostic biomarker and therapeutic target for melanoma. Biomed Res</text>
  <text x="361.587,363.993,368.117,370.523,373.038,377.163,381.287,385.411,389.536,391.553,395.678,399.802,403.926,408.128,410.145,414.27,418.394,422.518,426.643,430.767,434.892,439.016" y="217.07399999999996" svg_rhmargin="441.033" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Int 2017;2017:7038579.</text>
  <text x="345.203,347.609,351.733,355.857,358.26300000000003,361.586,367.339,371.075,375.2,378.82,384.185,388.697,390.714,394.296,399.661,403.785,407.521,411.646,415.214,420.58,424.316,426.33299999999997,429.954,435.319,439.444,443.18,447.304,451.03999999999996,454.614,462.086,467.451,469.468,473.038,476.304,478.71,482.279,486.015,488.032,490.049,493.673,498.186,502.311,506.435,510.171,513.741,517.865,521.99,526.114,529.38,533.504,537.628,539.646,543.77,547.506,551.099,556.463,562.605,567.97,571.564,575.688,581.053,586.02" y="226.03099999999995" svg_rhmargin="590.144" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[47] Gao YL, Zhao ZS, Zhang MY, et al. Long noncoding RNA PVT1</text>
  <text x="361.587,363.993,367.729,370.994,373.011,375.029,377.046,379.452,383.188,385.594,388.967,391.844,393.276,396.541,399.807,402.683,406.419,408.436,411.702,415.438,417.455,418.956,422.221,425.957,430.082,433.347,436.612,439.48900000000003,440.951,445.075,447.952,452.076,455.812,458.689,461.954,464.831,467.707,469.805,473.929,478.054,479.498,483.234,485.252,488.988,490.439,494.564,497.829,501.565,505.301,507.707,509.724,513.46,516.725,518.217,521.093,524.358,528.094,532.219,534.236,537.972,540.378,542.395,546.52,550.256,551.776,555.901,558.3069999999999,559.77,565.913,567.93,573.295,575.701,579.826,583.95,588.074" y="234.98800000000006" svg_rhmargin="590.091" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">facilitates cervical cancer progression via negative regulating of miR-424.</text>
  <text x="361.587,367.729,371.855,375.121,379.246,381.263,383.812,389.177,392.443,395.32,397.815,401.94,406.065,410.19,414.315,416.333,420.459,424.584,426.674,430.799,434.924,439.049" y="243.94500000000005" svg_rhmargin="443.173" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Oncol Res 2017;25:1391</text>
  <text x="443.168" y="243.94500000000005" svg_rhmargin="446.904" style="fill:#171615;font-family:NCNEBO+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="446.91,451.034" y="243.94500000000005" svg_rhmargin="453.051" style="fill:#171615;font-family:NCNEAO+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="85.039,91.591,95.65599999999999,98.305,102.37,104.68900000000001,107.319,111.384,112.795,114.947,117.58,124.132,128.196,132.755,134.166,138.231,139.642,143.874,147.939,150.574,152.479,156.879,161.278,165.678,170.077,171.982,174.554,178.954,183.353,185.505,189.905,194.304,517.041,522.931,528.821,534.711,536.863,543.414,547.973,550.874,552.285,556.685,560.917,563.3,567.532,571.597,573.008,575.16,579.224,583.624" y="9.870999999999981" svg_rhmargin="590.176" style="fill:#171615;font-family:NCNEAI+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Ma et al. Medicine (2018) 97:49 www.md-journal.com</text>
  <text x="333.185,337.585" y="739.625" svg_rhmargin="341.985" style="fill:#171615;font-family:NCNEJG+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">11</text>
 </g>
</svg>
